137 related articles for article (PubMed ID: 36580769)
1. Metal-organic framework for biomimetic nitric oxide generation and anticancer drug delivery.
Ji HB; Kim SN; Kim CR; Min CH; Han JH; Kim MJ; Lee C; Choy YB
Biomater Adv; 2023 Feb; 145():213268. PubMed ID: 36580769
[TBL] [Abstract][Full Text] [Related]
2. Fe-containing metal-organic framework with D-penicillamine for cancer-specific hydrogen peroxide generation and enhanced chemodynamic therapy.
Ji HB; Kim CR; Min CH; Han JH; Kim SN; Lee C; Choy YB
Bioeng Transl Med; 2023 May; 8(3):e10477. PubMed ID: 37206221
[TBL] [Abstract][Full Text] [Related]
3. ROS-induced NO generation for gas therapy and sensitizing photodynamic therapy of tumor.
Wan SS; Zeng JY; Cheng H; Zhang XZ
Biomaterials; 2018 Dec; 185():51-62. PubMed ID: 30218836
[TBL] [Abstract][Full Text] [Related]
4. Acid-Degradable Hydrogen-Generating Metal-Organic Framework for Overcoming Cancer Resistance/Metastasis and Off-Target Side Effects.
Yao X; Chen D; Zhao B; Yang B; Jin Z; Fan M; Tao G; Qin S; Yang W; He Q
Adv Sci (Weinh); 2022 Apr; 9(10):e2101965. PubMed ID: 35098699
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
6. Near infrared light triggered ternary synergistic cancer therapy via L-arginine-loaded nanovesicles with modification of PEGylated indocyanine green.
Wang K; Jiang L; Qiu L
Acta Biomater; 2022 Mar; 140():506-517. PubMed ID: 34902616
[TBL] [Abstract][Full Text] [Related]
7. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
[TBL] [Abstract][Full Text] [Related]
8. Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy.
Wang L; Chang Y; Feng Y; Li X; Cheng Y; Jian H; Ma X; Zheng R; Wu X; Xu K; Zhang H
Nano Lett; 2019 Oct; 19(10):6800-6811. PubMed ID: 31466437
[TBL] [Abstract][Full Text] [Related]
9. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cytotoxicity, loading, and release activity of paclitaxel loaded-porphyrin based metal-organic framework (PCN-600).
Hamidian K; Barani M; Adeli-Sardou M; Sarani M; Daliran S; Oveisi AR
Heliyon; 2023 Jan; 9(1):e12634. PubMed ID: 36647357
[TBL] [Abstract][Full Text] [Related]
11. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
12. A γ-cyclodextrin-based metal-organic framework embedded with graphene quantum dots and modified with PEGMA via SI-ATRP for anticancer drug delivery and therapy.
Jia Q; Li Z; Guo C; Huang X; Song Y; Zhou N; Wang M; Zhang Z; He L; Du M
Nanoscale; 2019 Nov; 11(43):20956-20967. PubMed ID: 31660562
[TBL] [Abstract][Full Text] [Related]
13. Nitrogen-doped Zn/Fe@PCN derived from metal-organic frameworks activating persulfate to efficiently degrade rhodamine B.
Zhong D; Liu P; Liu Y; Xu Y
Environ Sci Pollut Res Int; 2024 Jan; 31(2):2228-2242. PubMed ID: 38055169
[TBL] [Abstract][Full Text] [Related]
14. A novel nitric oxide-based anticancer therapeutics by macrophage-targeted poly(l-arginine)-based nanoparticles.
Kudo S; Nagasaki Y
J Control Release; 2015 Nov; 217():256-62. PubMed ID: 26386436
[TBL] [Abstract][Full Text] [Related]
15. Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy.
Kim J; Yung BC; Kim WJ; Chen X
J Control Release; 2017 Oct; 263():223-230. PubMed ID: 28034787
[TBL] [Abstract][Full Text] [Related]
16. Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy.
Ren Q; Yu N; Wang L; Wen M; Geng P; Jiang Q; Li M; Chen Z
J Colloid Interface Sci; 2022 May; 614():147-159. PubMed ID: 35091144
[TBL] [Abstract][Full Text] [Related]
17. Se/Ru-Decorated Porous Metal-Organic Framework Nanoparticles for The Delivery of Pooled siRNAs to Reversing Multidrug Resistance in Taxol-Resistant Breast Cancer Cells.
Chen Q; Xu M; Zheng W; Xu T; Deng H; Liu J
ACS Appl Mater Interfaces; 2017 Mar; 9(8):6712-6724. PubMed ID: 28191840
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic Metal-Organic Framework Composite-Mediated Cascade Catalysis for Synergistic Bacteria Killing.
Cheng X; Zhang S; Liu H; Chen H; Zhou J; Chen Z; Zhou X; Xie Z; Kuang Q; Zheng L
ACS Appl Mater Interfaces; 2020 Aug; 12(33):36996-37005. PubMed ID: 32697566
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic smart nanoplatform for dual imaging-guided synergistic cancer therapy.
Fang Z; Yang E; Du Y; Gao D; Wu G; Zhang Y; Shen Y
J Mater Chem B; 2022 Feb; 10(6):966-976. PubMed ID: 35072687
[TBL] [Abstract][Full Text] [Related]
20. Pro-oxidant drug-loaded porphyrinic zirconium metal-organic-frameworks for cancer-specific sonodynamic therapy.
Truong Hoang Q; Kim M; Kim BC; Lee CY; Shim MS
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 1):112189. PubMed ID: 34752984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
